Renal Dysfunction among Ghanaians Living with Clinically Diagnosed Hypertension in the Asutifi-South District: A Cross-Sectional Descriptive Study at the St. Elizabeth Hospital, Hwidiem
Table 6
Prevalence of renal dysfunction stratified by age and medication.
Parameter
CG
Rank
4v-MDRD
Rank
CKD-EPI
Rank
Age Category (years)
<50
2 (7.40)
4th
1 (3.70)
4th
1 (3.70)
4th
50-59
11 (22.00)
2nd
10 (20.00)
1st
10 (20.00)
1st
60-69
19 (21.35)
3rd
5 (5.62)
3rd
6 (6.74)
3rd
≥70
18 (56.25)
1st
3 (9.38)
2nd
4 (11.76)
2nd
Antihypertensive Medication
ACE Inhibitor
27 (24.32)
2nd
10 (9.01)
2rd
11 (9.91)
3rd
CC Blocker
36 (20.34)
4th
14 (7.91)
3rd
18 (10.17)
2nd
Diuretics
6 (23.08)
3rd
4 (15.38)
1st
4 (15.38)
1st
AR Blocker
17 (25.00)
1st
6 (8.82)
4th
6 (8.82)
4th
β-Blocker
1 (12.50)
5th
0 (0.00)
5th
0 (0.00)
5th
One
7 (29.17)
3rd
2 (8.33)
3rd
3 (12.50)
2nd
Two
24 (25.00)
4th
9 (9.38)
2nd
8 (6.56)
4th
Three
6 (31.58)
2nd
3 (15.79)
1st
8 (18.18)
1st
Four
1 (33.33)
1st
0 (0.0)
4rh
1 (10.00)
3rd
Data is presented as frequency with percentage in parenthesis. 4v-MDRD: four-variable modification of diet in renal disease, CG: Cockcroft-Gault, CKD-EPI: chronic kidney disease epidemiology collaboration. ACE inhibitor: angiotensin converting enzyme inhibitor, and CC blocker: calcium channel blocker.
